The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.
ICC International Cannabis Corp.’s (“ICC” or the “Company”) corporate mandate is to plan, design, build and operate the highest quality, lowest cost Cannabis production, processing and distribution facilities worldwide. ICC boasts an in-depth understanding of both the Cannabis and biomedical industries, as well as world-class experience within the many associated Cannabis industry vehicles and derivatives. The Company is equipped with a suite of comprehensive solutions for emerging companies within the Cannabis industry. ICC’s robust service offering allows the Company to formulate key alliances and critical associations within a wide range of Cannabis verticals.
Integrated Cannabis Company, Inc., d/b/a iCannaCo™, is a global wellness enterprise focused on the development, manufacturing, marketing and distribution of innovative and highly effective botanically-based consumable products.
International Cannabrands Inc. (ICI) acquired the exclusive rights to Julian Marley's JuJu Royal™ brand. ICI currently generates revenue from licensing brands to growers, edible manufacturers, oil extractors, producers of ancillary products and apparel in the United States where cannabis has been legalized at the state level, as well as products containing CBD in the US and internationally. ICI intends on acquiring micro brands with highly profitable operations in the cannabis space. The Company believes as the market becomes saturated with products varying in potency and quality, that the branded products will rise to the top and the Company intends to exploit all opportunities available to realize the full value of the Julian Marley brand and other brands.
The Company is engaged in the commercialization of proprietary diagnostic products for breast cancer. Its business strategy is to complete the commercial development of 360 degree, true 3D breast imaging technology for early diagnosis of breast cancer. The Company holds a license under a license agreement to make, have made, use, offer for sale, import, and sell products and services and to practice processes and methods in the field of human diagnostics and therapeutics in the United States and any other countries where approvals are granted or where patent rights may exist in the future with respect to certain licensed patent rights.
The Company is engaged in the business of producing nutritional beverage drinks using a proprietary blend of nootropics and natural organic compounds to enhance human productivity without using harmful chemicals or stimulants.
Lexington Biosciences, Inc. is a development stage medical device company operating within the healthcare industry. Lexington is focused on development and commercialization of non-invasive cardiovascular health monitoring products to allow predictive diagnosis of future cardiovascular events. The current focus of the company is to develop and market the HeartSentry endothelial function measurement product.
Liberty Health Sciences Inc. is an investor and operator in the medical cannabis market, capitalizing on new and existing opportunities in the United States.
Liberty Leaf Holdings Ltd. is a new, Canadian-based, public company whose objective is to be at the forefront of the medicinal and recreational cannabis industry...accelerating revenue-generating businesses within this dynamic and fast-growing sector.
Lifestyle Delivery Systems Inc.’s filmstrip technologies produce an oral delivery system that can be used for energy elixirs, herbal remedies and a smokeless alternative option to medical and recreational users of cannabis. The Company’s technology produces infused strips (similar to breath strips) that are not only a safer, healthier option to smoking but also a new way to accurately meter the dosage and assure the purity of the product. The Company will license the technology to licensees, who will in turn manufacture the strips where the legal use of marijuana is allowed.